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Previewsask questions is limited to the tools that
are available to us. The development
and application of new imaging methods
with higher speed and greater resolution
will lead us to new information and novel
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Fas is a cell surface death receptor critical for immune regulation. In this issue of Immunity, Butt et al. (2015)
show that Fas eliminates B cells that have become uncoupled from positive and negative selection in the
germinal center.As a death receptor that can trigger
apoptosis of activated lymphocytes, Fas
plays an important role in curtailing im-
mune responses. Strikingly, mutations in
Fas, its ligand, ormajor downstream com-
ponents can lead to an autoimmune lym-
phoproliferative syndrome (ALPS) in both
mice and humans. Germinal center (GC)
B cells express high amounts of Fas and
conditional deletion of Fas in GC and
other activated B cells recapitulated
many features of ALPS (Hao et al.,
2008), suggesting that the GC is a major
site of Fas-mediated regulation. However,
the mechanism by which Fas regulates
GC B cell homeostasis has remained
enigmatic for nearly two decades. In this
issue, Butt et al. (2015) provide new in-
sights into this longstanding question.
In this study, the role of Fas in the B cell
response was probed in an elegant, well-
characterized model previously estab-
lished in the Brink laboratory. This model
is based on a now-classical system in
which B cells express a B cell receptor
(BCR) specific for hen egg lysozyme(HEL). Brink’s laboratory previously
generated a knock-in mouse (so-called
‘‘switch’’ HEL or SWHEL) in which B cells
can undergo the normal processes of
somatic hypermutation (SHM) and class
switch recombination. Although this
BCR has very high affinity for HEL, the
authors used mutated HEL with amino
acid substitutions resulting in moderate
affinity (HEL3X) or negligible affinity
(HEL4X), which were introduced as a
foreign or self antigen, respectively. In
GC B cells, specific BCR somatic muta-
tions were identified that increased affin-
ity for the foreign antigen (HEL3X) or
decreased affinity for the self antigen
(HEL4X). This system enables the authors
to probe GC selection mechanisms that
enhance affinity and those that prevent
self-reactivity.
The early response of SWHEL B cells
was generally unaffected by Fas defi-
ciency, because Fas was not essential
for affinity maturation and the elimination
of autoreactive B cells in the early GC,
similar to several prior studies. Curiously,however, over time the authors observed
the unusual emergence of large numbers
of plasma cells (PCs) derived from Fas-
deficient SWHEL B cells. Most of these
PCs had acquired additional mutations
that decreased antibody affinity for the
foreign antigen HEL3X, and some cells
had mutations that increased affinity for
the autoantigen HEL4X. The authors pro-
vided evidence suggesting that these
Fas-deficient PCs arose from GCs late in
the response. For example, disruption of
T cell help by blockade of CD40 ligand
(CD40L), which is necessary for the
ongoing maintenance of GCs, prevented
the accumulation of Fas-deficient PCs.
In addition, a thorough analysis of the
BCR somatic mutation patterns revealed
that the aberrant PCs were clonally
related to rare B cells in GCs. Based on
these findings, the authors proposed
that Fas deficiency leads to the emer-
gence of ‘‘rogue’’ GC B cells that escape
normal antigen-mediated positive and
negative selection and readily differen-
tiate into PCs (Figure 1).42, May 19, 2015 ª2015 Elsevier Inc. 783
Figure 1. Fas Prevents the Accumulation of ‘‘Rogue’’ Cells
The composition of B cells in GCs (oval structures) is shown over time. In the early GC, the selection for
high-affinity mutants and the elimination of autoreactive mutants occurs normally in the presence or
absence of Fas. However, in late GCs, Fas-deficient B cells that acquire detrimental mutations (and
thereby lost high affinity) can survive as ‘‘rogue’’ cells and preferentially differentiate into large numbers
of PCs. In addition, a subset of these Fas-deficient rogue cells acquire mutations leading to autoantibody
production.
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PreviewsThe observed perturbation in GC selec-
tion bears resemblance to an earlier study
in Fas-deficient mice that extensively
characterized the pattern of somatic mu-
tations in B cells specific for a hapten
(Takahashi et al., 2001). Fas deficiency
led to the excessive accumulation of
hapten-specific memory B cells with an
unusually high number of somatic muta-
tions several weeks after immunization.
Similar to the Butt et al. (2015) findings
with PCs, Takahashi et al. (2001) found
that CD40L blockade at late time points
prevented the accumulation of these
abnormal memory cells in Fas-deficient
mice. Based on these findings, Takahashi
et al. (2001) proposed that in Fas-deficient
mice, defective selection in lateGCs led to
the abnormal ongoing generation ofmem-
ory B cells. Takahashi et al. (2001) did not
evaluate PC accumulation, which was the
focus of the Butt et al. (2015) study; inter-
estingly, Butt et al. (2015) also observed a
late accumulation of memory B cells
derived from Fas-deficient SWHEL B cells.
An accumulation of memory B cells was
also reported in a study of mice in which
Fas was conditionally deleted in B cells
(Hao et al., 2008). Taken together, these
data indicate that Fas deficiency in B cells
leads to an abnormal accumulation of
both PCs and memory B cells at later
stages of the immune response.784 Immunity 42, May 19, 2015 ª2015 ElseviThese groups favor the model that
within the late GC, B cells deficient in
Fas can escape checkpoints leading to
inappropriate survival and differentiation.
How can this death receptor have such
a profound impact on selection in the
late, but not early, GC? One possibility is
a multiple hit model, similar to oncogen-
esis. During SHM of immunoglobulin
genes in the GC, other genes occasionally
are inadvertently mutated. Perhaps muta-
tion of other gene(s) in addition to Fas is
needed for the ‘‘rogue’’ GC B cells to sur-
vive and differentiate; such bystander
gene mutation might be more likely to
occur at late time points after many
rounds of mutation and proliferation
within the GC. A second possibility is
that the ‘‘rogue’’ GC B cells survive and
differentiate due to indirect effects of
Fas deficiency that accumulate with
time. For example, conditional deletion
of Fas in B cells was reported to lead to
perturbations in the T cell compartment
(Hao et al., 2008); atypical T cell help
could promote aberrant GC B cell selec-
tion at late stages of the response. A third
possibility stems from old observations
that BCR signals can prevent cell death
when Fas is ligated (Rothstein et al.,
1995). Recent evidence suggests that a
subset of GC B cells undergo active
BCR signaling (Mueller et al., 2015).er Inc.Perhaps in later stages of the GC
response, BCR signaling is required to
prevent Fas-mediated apoptosis; how-
ever, in the absence of Fas, GC B cells
that have acquired deleterious BCRmuta-
tions might be able to survive and differ-
entiate. Finally, it is also possible that the
aberrant PCs are not directly derived
from the GC B cells but rather from other
activated B cell intermediates, such
as the abnormal memory cells that accu-
mulate in the absence of Fas. SHM has
also been reported outside of GCs in
Fas-deficient mice (William et al., 2002).
A key unanswered question remaining to
be addressed is: why do most of the
Fas-deficient PCs that abnormally accu-
mulate have BCR somatic mutations that
decrease affinity and/or increase autor-
eactivity, whereas such cells are found
only rarely in Fas-deficient GCs?
In addition to the intriguing observa-
tions about the role of Fas in GC selection,
Butt et al. (2015) observed greatly
elevated concentrations of serum IgE
when the SWHEL B cells lacked Fas,
concomitant with an accumulation of IgE
PCs late in the response. Interestingly,
such an accumulation of IgE-expressing
cells was not observed in the GC, similar
to findings in mice overexpressing the
anti-apoptotic protein Bcl-2 (Yang et al.,
2012). These data are consistent with
the notion that IgE-switched cells might
be biased toward PC differentiation and
further suggest that IgE PCs might
be particularly susceptible to apoptosis.
Increased serum IgE in Fas-deficient
mice was also recently reported by
another group on the BALB/c strain
background, although this group could
not confirm with statistical confidence
that serum IgE was elevated in Fas-defi-
cient C57BL/6 mice (Futatsugi-Yumikura
et al., 2014), in contrast to the Butt et al.
(2015) studies. Further evidence for the
relevance of Fas deficiency on serum
IgE concentrations in humans was pro-
vided by Butt et al. (2015) by retrospec-
tively analyzing data from ALPS patients
and identifying a cohort with elevated
serum IgE concentrations. This analysis
confirms a prior report of elevated IgE in
a subset of ALPS patients (Kim et al.,
2007). Therefore, we can reasonably
conclude that Fas deficiency, at least
under some circumstances, can lead to
increased IgE. Notably, the increase in
IgE might not be specific to this isotype,
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Previewsbecause IgG1 PC responses were also
greatly elevated when mice received
Fas-deficient SWHEL B cells. Overall,
these findings of Butt et al. (2015) draw
further attention to the idea that excessive
IgE might be produced in autoimmune
disorders in addition to allergic diseases.
The potential contribution of IgE autoanti-
bodies to autoimmune disease pathogen-
esis, as recently observed in a mouse
model of lupus (Dema et al., 2014), merits
further study.
Overall, the Butt et al. (2015) paper
highlights the critical role of Fas in late
stages of B cell selection and differentia-
tion. The authors have proposed that in
the absence of Fas, a small subset
of ‘‘rogue’’ GC B cells escape normal
regulatory constraints leading to theaccumulation of aberrant populations of
PCs, including IgE PCs. However, the
mechanistic basis by which Fas defi-
ciency leads to these outcomes remains
largely unknown.REFERENCES
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IRF4-dependent DCs have been associated with induction of both Th1 and Th17 cells. In this issue of Immu-
nity, Tussiwand et al. (2015) demonstrate that a dependence on KLF4 identifies a subset of IRF4-dependent
DC that preferentially promotes Th2 cell differentiation.Dendritic cells (DCs) are a diverse group
of phagocytic cells that are distributed
throughout the body and whose primary
function relates to the capture and presen-
tation of antigen to naive T cells (Heath and
Carbone, 2009). DCs can be divided into
those that primarily reside in lymphoid tis-
sues (resident DCs) and so-called migra-
tory DCs that reach lymphoid organs
upon immigration from peripheral tissues
via the lymphatics. In addition to this
differential distribution pattern, DCs are
also characterized by an intriguing func-
tional heterogeneity. DCs expressing
the chemokine receptor XCR1 have supe-
rior abilities to stimulate CD8+ T cell re-
sponses and depend on the transcription
factors IRF8, BATF3, ID2, and NFIL3.
Another major subset of DCs expresseshigh levels of CD11b, is functionally
biased toward the activation of major
histocompatibility complex class II mole-
cule (MHC-II)-restricted CD4+ T cell
responses, and has transcriptional re-
quirements for IRF4. Notably, this cohort
of CD11bhi DCs appears to be consider-
ably more heterogeneous relative to the
XCR1+ lineage with varying dependence
on the transcription factors RELB and
TRAF6 and diverse expression patterns
of surface molecules that include SIRPa,
CD24, CD4, CD205, or CD103. The poten-
tial diversity within the CD11bhi population
of DCs is further highlighted by differing
effects on the induction of CD4+ T cell
responses. Some reports have linked
IRF4-dependent DCs to a heightened pro-
pensity to induce a T helper 17 (Th17) celldifferentiation program in CD4+ T cells
(Persson et al., 2013; Schlitzer et al.,
2013), whereas other studies suggest that
IRF4-dependent DCs preferentially imprint
CD4+ T cells with a Th2 cell phenotype
(Gao et al., 2013; Kumamoto et al., 2013).
To shed light on the potential diversity
within the CD11bhi population of DCs,
Tussiwand et al. analyzed expression
of transcription factors and noted that
CD11bhi DCs preferentially expressed
both IRF4 and Kru¨ppel-like factor 4
(KLF4) (Tussiwand et al., 2015). This tran-
scription factor is required for the differ-
entiation of keratinocytes, smooth muscle
cells, and endothelial cells and has previ-
ously been associated with monocyte
development and the presence of
CD11bhi DC. To resolve whether KLF442, May 19, 2015 ª2015 Elsevier Inc. 785
